HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wendy M Smith Selected Research

Thiazolidinediones

10/2002APC-dependent suppression of colon carcinogenesis by PPARgamma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wendy M Smith Research Topics

Disease

5Uveitis
10/2022 - 09/2012
3Inflammation (Inflammations)
01/2019 - 06/2012
2Panuveitis
10/2022 - 01/2014
2Histoplasmosis
07/2022 - 01/2019
2Cataract (Cataracts)
01/2021 - 01/2018
2Macular Edema
01/2021 - 09/2012
1Whipple Disease (Whipple's Disease)
11/2023
1Iritis
09/2023
1Lymphoma (Lymphomas)
09/2023
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2023
1Endophthalmitis (Ophthalmia)
11/2022
1Disease Progression
10/2022
1Dry Eye Syndromes (Dry Eye Syndrome)
10/2022
1Choroidal Neovascularization
07/2022
1Retinal Diseases
06/2021
1Optic Neuritis (Retrobulbar Neuritis)
01/2020
1Scleritis (Episcleritis)
01/2018
1Hemorrhage
01/2018
1Tuberculosis (Tuberculoses)
08/2016
1Osteonecrosis (Kienbock's Disease)
04/2013
1Raynaud Disease (Raynaud's Disease)
04/2013
1Sickle Cell Trait
04/2013
1Thalassemia
04/2013
1Mycoses (Diseases, Fungus)
02/2013
1Vasculitis (Vasculitides)
09/2012
1Retinal Vasculitis
09/2012
1Infections
09/2012
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2012
1Anterior Uveitis
06/2012
1Anosmia
07/2010
1Insulin Resistance
10/2002
1Carcinogenesis
10/2002
1Colonic Neoplasms (Colon Cancer)
10/2002
1Type 2 Diabetes Mellitus (MODY)
10/2002
1Neoplasms (Cancer)
10/2002
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
05/2002
1Glomus Tumor (Glomus Tumors)
05/2002
1Pheochromocytoma
05/2002
1von Hippel-Lindau Disease (von Hippel Lindau Disease)
05/2002

Drug/Important Bio-Agent (IBA)

3Adrenal Cortex Hormones (Corticosteroids)IBA
10/2022 - 09/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2022 - 01/2018
2prednisolone acetateFDA LinkGeneric
09/2023 - 02/2013
1Periodic AcidIBA
11/2023
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
11/2023
1Methotrexate (Mexate)FDA LinkGeneric
09/2023
1Interleukin-10 (Interleukin 10)IBA
09/2023
1Endothelial Growth FactorsIBA
11/2022
1encorafenibIBA
10/2022
1VemurafenibIBA
10/2022
1dabrafenibIBA
10/2022
1Biomarkers (Surrogate Marker)IBA
06/2021
1Retinaldehyde (Retinal)IBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2017
1SteroidsIBA
08/2016
1Viral DNAIBA
01/2014
1AutoantibodiesIBA
04/2013
1Voriconazole (Vfend)FDA LinkGeneric
02/2013
1Ophthalmic Solutions (Eye Drops)IBA
02/2013
1Rifabutin (Ansamycin)FDA Link
09/2012
1Fluorescein (Funduscein)FDA LinkGeneric
09/2012
1Sirolimus (Rapamycin)FDA Link
06/2012
1ZincIBA
07/2010
1gluconic acid (gluconate)FDA LinkGeneric
07/2010
1AzoxymethaneIBA
10/2002
1PPAR gammaIBA
10/2002
1beta CateninIBA
10/2002
1LigandsIBA
10/2002
1ThiazolidinedionesIBA
10/2002
1Succinate Dehydrogenase (Fumarate Reductase)IBA
05/2002

Therapy/Procedure

4Therapeutics
10/2022 - 10/2002
3Injections
11/2022 - 01/2018
1Perioperative Period
01/2021
1Immunomodulation
01/2019
1Highly Active Antiretroviral Therapy (HAART)
02/2013